Literature DB >> 30637659

Analysis of culturable microbiota present in the stomach of children with gastric symptoms.

Changcheng Guo1, Fang Liu1, Li Zhu2, Fangcao Wu1, Guzhen Cui1, Yan Xiong2, Qiong Wang1, Lin Yin1, Caixia Wang1, Huan Wang1, Xiaojuan Wu1, Zhengrong Zhang1, Zhenghong Chen3,4.   

Abstract

Despite extensive studies on the gastric microbiota, including Helicobacter pylori and non-H. pylori, the bacterial composition in children remains unknown. In this study, we analyzed the culturable gastric bacteria in stomach biopsies from 346 children aged 1-15 years affected by gastric diseases. H. pylori and non-H. pylori were identified by specific PCR and 16S rDNA sequencing, respectively. Antibiotic susceptibilities of H. pylori and non-H. pylori were tested by the E-test and disk diffusion methods, respectively. Rapid diagnosis was also performed by H. pylori-specific PCR. Twenty-two H. pylori strains were obtained from culture, and 92 biopsies were positive by H. pylori-specific PCR. The positive rate was higher in boys (40.3%) than in girls (23.3%) (P = 0.001). Resistance rates of 22 H. pylori strains were as follows: metronidazole, 86.4%; tetracycline, 22.7%; amoxicillin, 22.7%; levofloxacin, 31.8%; clarithromycin, 36.4%. Ten isolates were multidrug-resistant. Additionally, among 366 non-H. pylori strains, 204 exhibited urease activity. Non-H. pylori resistance rates were as follows: metronidazole, 94.8%; tetracycline, 26.2%; amoxicillin, 42.6%; levofloxacin, 15.3%; clarithromycin, 46.7%. Our results showed that children with gastric disorders harbor stomach bacteria with urease activity or nitrate reductase activity. Further studies will determine the effects of non-H. pylori bacteria in gastric diseases.

Entities:  

Keywords:  Gastric microbiota; Helicobacter pylori; Resistance; Urease

Mesh:

Substances:

Year:  2018        PMID: 30637659      PMCID: PMC6863212          DOI: 10.1007/s42770-018-0030-5

Source DB:  PubMed          Journal:  Braz J Microbiol        ISSN: 1517-8382            Impact factor:   2.476


  50 in total

Review 1.  The role of gut microbiota (commensal bacteria) and the mucosal barrier in the pathogenesis of inflammatory and autoimmune diseases and cancer: contribution of germ-free and gnotobiotic animal models of human diseases.

Authors:  Helena Tlaskalová-Hogenová; Renata Stěpánková; Hana Kozáková; Tomáš Hudcovic; Luca Vannucci; Ludmila Tučková; Pavel Rossmann; Tomáš Hrnčíř; Miloslav Kverka; Zuzana Zákostelská; Klára Klimešová; Jaroslava Přibylová; Jiřina Bártová; Daniel Sanchez; Petra Fundová; Dana Borovská; Dagmar Srůtková; Zdeněk Zídek; Martin Schwarzer; Pavel Drastich; David P Funda
Journal:  Cell Mol Immunol       Date:  2011-01-31       Impact factor: 11.530

Review 2.  Gastric microbiome and gastric cancer.

Authors:  Kyle M Brawner; Casey D Morrow; Phillip D Smith
Journal:  Cancer J       Date:  2014 May-Jun       Impact factor: 3.360

3.  Gastric bacterial overgrowth is a cause of false positive diagnosis of Helicobacter pylori infection using 13C urea breath test.

Authors:  L Michaud; F Gottrand; P S Ganga-Zandzou; N Wizla-Derambure; D Turck; P Vincent
Journal:  Gut       Date:  1998-04       Impact factor: 23.059

4.  Neisseria flavescens: A Urease-Expressing Potential Pathogen Isolated from Gastritis Patients.

Authors:  Bo Zeng; Lijin Sun; Yongmei Chen; Yin Qian; Qian Cao; Zhi Zhang; Zaixin Li
Journal:  Curr Microbiol       Date:  2017-10-24       Impact factor: 2.188

Review 5.  The Esophageal and Gastric Microbiome in Health and Disease.

Authors:  Richard H Hunt; Mohammad Yaghoobi
Journal:  Gastroenterol Clin North Am       Date:  2017-03       Impact factor: 3.806

6.  Phenotypic and Molecular Antimicrobial Susceptibility of Helicobacter pylori.

Authors:  Derrick Chen; Scott A Cunningham; Nicolynn C Cole; Peggy C Kohner; Jayawant N Mandrekar; Robin Patel
Journal:  Antimicrob Agents Chemother       Date:  2017-03-24       Impact factor: 5.191

7.  Efficacy of genotypic resistance-guided sequential therapy in the third-line treatment of refractory Helicobacter pylori infection: a multicentre clinical trial.

Authors:  Jyh-Ming Liou; Chieh-Chang Chen; Chi-Yang Chang; Mei-Jyh Chen; Yu-Jen Fang; Ji-Yuh Lee; Chien-Chuan Chen; Shih-Jer Hsu; Yao-Chun Hsu; Cheng-Hao Tseng; Ping-Huei Tseng; Lawrence Chang; Wen-Hsiung Chang; Hsiu-Po Wang; Chia-Tung Shun; Jeng-Yih Wu; Yi-Chia Lee; Jaw-Town Lin; Ming-Shiang Wu
Journal:  J Antimicrob Chemother       Date:  2012-10-25       Impact factor: 5.790

8.  Multilocus sequence typing of Ochrobactrum spp. isolated from gastric niche.

Authors:  Girish Kulkarni; Kushal Gohil; Vatsala Misra; Arjun L Kakrani; Sri P Misra; Milind Patole; Yogesh Shouche; Mahesh Dharne
Journal:  J Infect Public Health       Date:  2016-06-08       Impact factor: 3.718

9.  Antimicrobial susceptibility testing for Helicobacter pylori isolates from Brazilian children and adolescents: comparing agar dilution, E-test, and disk diffusion.

Authors:  Silvio Kazuo Ogata; Ana Cristina Gales; Elisabete Kawakami
Journal:  Braz J Microbiol       Date:  2015-03-04       Impact factor: 2.476

10.  Gastric microbial community profiling reveals a dysbiotic cancer-associated microbiota.

Authors:  Rui M Ferreira; Joana Pereira-Marques; Ines Pinto-Ribeiro; Jose L Costa; Fatima Carneiro; Jose C Machado; Ceu Figueiredo
Journal:  Gut       Date:  2017-11-04       Impact factor: 23.059

View more
  4 in total

1.  The Effects of Helicobacter pylori Infection on Gastric Microbiota in Children With Duodenal Ulcer.

Authors:  Wei Zheng; Zhenya Zhu; Jingjing Ying; Gao Long; Bo Chen; Kerong Peng; Fubang Li; Hong Zhao; Mizu Jiang
Journal:  Front Microbiol       Date:  2022-04-25       Impact factor: 6.064

2.  Gastric Non-Helicobacter pylori Urease-Positive Staphylococcus epidermidis and Streptococcus salivarius Isolated from Humans Have Contrasting Effects on H. pylori-Associated Gastric Pathology and Host Immune Responses in a Murine Model of Gastric Cancer.

Authors:  Zeli Shen; JoAnn Dzink-Fox; Yan Feng; Sureshkumar Muthupalani; Anthony J Mannion; Alexander Sheh; Mark T Whary; Hilda R Holcombe; Blanca M Piazuelo; Luis E Bravo; Christine Josenhans; Sebastian Suerbaum; Keith T Wilson; Richard M Peek; Timothy C Wang; James G Fox
Journal:  mSphere       Date:  2022-02-09       Impact factor: 5.029

Review 3.  The Challenges of Eradicating Pediatric Helicobacter pylori Infection in the Era of Probiotics.

Authors:  Lorena Elena Meliț; Cristina Oana Mărginean; Maria Oana Săsăran
Journal:  Children (Basel)       Date:  2022-05-28

4.  Analysis of serum gastrin-17 and Helicobacter pylori antibody in healthy Chinese population.

Authors:  Wenjun Liu; Youxiang Sun; Yulin Yuan
Journal:  J Clin Lab Anal       Date:  2020-08-30       Impact factor: 3.124

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.